Peptide record

TPDB09216

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09216
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb i2APP
standard
No
A 19-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GPVGLLSSPGSLPPVGGAP
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C75H123N19O23
RNDCEQHIKMFTWY
GP
1658.92
6.02
0
0
6
-0
-1.01
0.484
97.37
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
5
G
0
H
0
I
3
L
0
K
0
M
0
F
5
P
3
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 5 H: 0 I: 0 L: 3 K: 0 M: 0 F: 0 P: 5 S: 3 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
19 reviewed residue count
C75H123N19O23 sequence-only estimate (linear, free termini)
1658.92 sequence-only estimate (linear, free termini)
6.02 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-1.01 sequence-only estimate (linear, free termini)
0.484 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Diffusion assays (20 ug peptide): Active against B. subtilis (inhibition diameter: 19.04 mm), X. campestris pv. Vesicatoria (16.47 mm), P. solanacearum (10.75 mm), P. wickerhami (10.3 mm), B. megaterium (7.3 mm). Active against fungi: P. capsici (23.06% inhibition), V. dahliae (52.46% inhibition), F. graminearum (23.94% inhibition), and F. omysporum (14.6% inhibition). Interstingly, the same peptide has also been identified in Lactobacillus crustorum MN047 ( Yi et al., 2018 ). Inhibition zone assays reveal broad-spectrum activity. active against Gram+ S. aureus ATCC 29213, 25923 (19.1-19.2 mm), E. faecalis ATCC 29212 (10.3 mm), L. monocytogenes CMCC 54004 (17.2 mm), Gram- E. coli ATCC 25922 (17.0 mm), Salmonella CMCC 50071 (18.7 mm), C. sakazakii ATCC 29544 (18 mm), also active against antibiotic0resistant C. sakazakii (16.9-18.4 mm) and Salmonella 557D (15.6 mm). Found in multiple species. Updated 7/2021
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Diffusion assays (20 ug peptide): Active against B. subtilis (inhibition diameter: 19.04 mm), X. campestris pv. Vesicatoria (16.47 mm), P. solanacearum (10.75 mm), P. wickerhami (10.3 mm), B. megaterium (7.3 mm). Active against fungi: P. capsici (23.06% inhibition), V. dahliae (52.46% inhibition), F. graminearum (23.94% inhibition), and F. omysporum (14.6% inhibition). Interstingly, the same peptide has also been identified in Lactobacillus crustorum MN047 ( Yi et al., 2018 ). Inhibition zone assays reveal broad-spectrum activity. active against Gram+ S. aureus ATCC 29213, 25923 (19.1-19.2 mm), E. faecalis ATCC 29212 (10.3 mm), L. monocytogenes CMCC 54004 (17.2 mm), Gram- E. coli ATCC 25922 (17.0 mm), Salmonella CMCC 50071 (18.7 mm), C. sakazakii ATCC 29544 (18 mm), also active against antibiotic0resistant C. sakazakii (16.9-18.4 mm) and Salmonella 557D (15.6 mm). Found in multiple species. Updated 7/2021
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

DRAMP

Other

Diffusion assays (20 ug peptide): Active against B. subtilis (inhibition diameter: 19.04 mm), X. campestris pv. Vesicatoria (16.47 mm), P. solanacearum (10.75 mm), P. wickerhami (10.3 mm), B. megaterium (7.3 mm). Active against fungi: P. capsici (23.06% inhibition), V. dahliae (52.46% inhibition), F. graminearum (23.94% inhibition), and F. omysporum (14.6% inhibition). Interstingly, the same peptide has also been identified in Lactobacillus crustorum MN047 ( Yi et al., 2018 ). Inhibition zone assays reveal broad-spectrum activity. active against Gram+ S. aureus ATCC 29213, 25923 (19.1-19.2 mm), E. faecalis ATCC 29212 (10.3 mm), L. monocytogenes CMCC 54004 (17.2 mm), Gram- E. coli ATCC 25922 (17.0 mm), Salmonella CMCC 50071 (18.7 mm), C. sakazakii ATCC 29544 (18 mm), also active against antibiotic0resistant C. sakazakii (16.9-18.4 mm) and Salmonella 557D (15.6 mm). Found in multiple species. Updated 7/2021
Evidence 4 Activity

Activity

Antiviral

Source & Reference

DRAMP

Other

Diffusion assays (20 ug peptide): Active against B. subtilis (inhibition diameter: 19.04 mm), X. campestris pv. Vesicatoria (16.47 mm), P. solanacearum (10.75 mm), P. wickerhami (10.3 mm), B. megaterium (7.3 mm). Active against fungi: P. capsici (23.06% inhibition), V. dahliae (52.46% inhibition), F. graminearum (23.94% inhibition), and F. omysporum (14.6% inhibition). Interstingly, the same peptide has also been identified in Lactobacillus crustorum MN047 ( Yi et al., 2018 ). Inhibition zone assays reveal broad-spectrum activity. active against Gram+ S. aureus ATCC 29213, 25923 (19.1-19.2 mm), E. faecalis ATCC 29212 (10.3 mm), L. monocytogenes CMCC 54004 (17.2 mm), Gram- E. coli ATCC 25922 (17.0 mm), Salmonella CMCC 50071 (18.7 mm), C. sakazakii ATCC 29544 (18 mm), also active against antibiotic0resistant C. sakazakii (16.9-18.4 mm) and Salmonella 557D (15.6 mm). Found in multiple species. Updated 7/2021